Do You Know a Pharmaceutical Paid Over $642 Million to Settle Allegations of Improper Payments?

This video delves into the repercussions of inadequate compliance monitoring, spotlighting a major pharmaceutical company's costly lesson in ethical oversight. Facing staggering fines and severe reputation damage, the company shelled out a whopping $642 million in settlements for False Claims Act violations. Watch as we dissect the two pivotal settlements: the first, a $51.25 million agreement, exposes the company's covert use of three foundations to mask copays, while the second, a staggering

Configure And Track Your Monitoring Plan

Create and Track Risk Mitigation Plan

Stay Compliant By Monitoring The Right Reps

Review highly rated HCPs and speakers